相关实验视频

Updated: Jun 3, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

血清GDF-15和IL-6对癌症免疫治疗反应的影响:一项前性研究

Orhun Akdogan¹, Sena Turkmen², Galip Can Uyar³

¹Department of Medical Oncology, Gazi University, 06560 Ankara, Türkiye.

|January 8, 2025

概括

血清生长分化因子15 (GDF-15) 预测了癌症患者的免疫治疗反应和缓解症. 升高的GDF-15表明生存率较差,并增加了缓解症风险,这表明其预后价值.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
生物标志物发现发现

背景情况:

免疫疗法已经彻底改变了癌症治疗,但预测患者的反应仍然是一个重大挑战.
血清生物标志物为识别可能从免疫治疗中受益的患者提供了一个有希望的途径.

研究的目的:

评估血清生长差异化因子15 (GDF-15) 和白蛋白-6 (IL-6) 水平与接受二线免疫治疗的癌症患者的治疗结果之间的关联.
探索GDF-15和IL-6作为免疫疗法疗效和缓解症的潜在预后生物标志物.

主要方法:

进行了一项前性观察性研究,85名患者被诊断为非小细胞肺癌,细胞癌或恶性黑色素瘤.
患者接受了尼沃卢马布治疗,并且使用ELISA套件量化了基线GDF-15和IL-6的血清水平.
主要终点包括无进展生存率 (PFS) 和整体生存率 (OS),其次要结果是缓解症发病率.

主要成果:

显著升高的GDF-15水平与较短的PFS (HR:0.55) 和OS (HR:0.47) 相相关.
较高的IL-6水平表明PFS较短的趋势,但没有达到统计学意义.
增加的GDF-15水平与更高的缓解症发病率相关 (p = 0.037).

结论:

GDF-15显示出作为预后生物标志物的潜力,用于预测癌症患者的免疫治疗反应.
此外,GDF-15还可以作为治疗食症的治疗点,用于治疗与癌症有关的食症.
需要进一步的研究来研究GDF-15在接受免疫治疗的癌症患者的治疗决策指导中的临床实用性.

关键词:

增长差异化因素15 (GDF-15) 是一个增长差异化因素.介质素-6 (IL-6) 介质素-6 (IL-6) 介质素-6 (IL-6) 介质素-6 (IL-6) 介质素-6 (IL-6) 介质素-6) 介质素-6 (IL-6) 介质素-6 (IL-6) 介质素-6) 介质素-6 (IL-6)免疫疗法反应的免疫疗法反应

更多相关视频

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...